Can I read P2Y12 Inhibitor vs Aspirin in CAD on EtoBox?

P2Y12 Inhibitor vs Aspirin in CAD by guilherme.maierr is a document available to read on EtoBox.

What is P2Y12 Inhibitor vs Aspirin in CAD about?

This study compares the efficacy and safety of P2Y12 inhibitor monotherapy versus aspirin monotherapy for secondary prevention of cardiovascular events in patients with coronary artery disease (CAD). The results indicate that P2Y12 inhibitors significantly reduce the risk of cardiovascular death, myocardial infarction, and stroke compared to aspirin, with similar rates of major bleeding. Therefore, P2Y12 inhibitor monotherapy may be preferred for long-term secondary prevention in CAD patients due to its sup

Author

guilherme.maierr

Language

EN